Understanding Chronic Lymphocytic Leukemia
NCT04028531 · Phase II · Boston, Massachusetts, United States
- Condition
- Leukemia
- Disease stage
- Stage I-IV
- Phase
- Phase II
- Study type
- Targeted Therapy
- Age
- 18 Years to
- Gender
- All
- Sponsor
- Dana-Farber Cancer Institute
- Research institution
- Dana-Farber Cancer Institute
- Facility
- Dana Farber Cancer Institute
- Research center
- Dana Farber Cancer Institute
Summary
The purpose of this study is to collect human Chronic Lymphocytic Leukemia tissue samples and medical information, in order to find out more about the causes and biology of chronic lymphocytic leukemia.
Detailed description
The purpose of this study is to collect human Chronic Lymphocytic Leukemia tissue samples and medical information, in order to find out more about the causes and biology of chronic lymphocytic leukemia, for the potential development of more effective therapies for this disease.
Inclusion criteria
* New and existing patients seen for treatment of monoclonal B-cell lymphocytosis * Any low grade lymphoproliferative disorder * Chronic Lymphocytic Leukemia in the Dana Farber Cancer Institute Hematologic Oncology Clinic or elsewhere
Exclusion criteria
\-
Primary outcomes
Incidence of novel genomic prognostic markers in Chronic Lymphocytic Leukemia